This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Universitätsmedizin Der Johannes Gutenberg-Universitat Mainz, Other. Active years: 2013-2020.
Company Filing History:
1 out of 18 
1 out of 834,411 Years Active: 2013-2020
Title: The Innovations of Tobias Bopp
Introduction
Tobias Bopp is a notable inventor based in Aabergen, Germany. He has made significant contributions to the field of immunology, particularly in the activation of regulatory T-cells. His work has implications for the treatment of various autoimmune diseases and allergies.
Latest Patents
Tobias Bopp holds 2 patents. His latest patents include a screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4. This invention relates to the specific activation of regulatory T-cells via a specific CD4 epitope, which can be utilized for the treatment of autoimmune diseases, allergies, asthma, graft rejection, and tolerance induction.
Career Highlights
Throughout his career, Tobias Bopp has worked with prestigious institutions, including Universitätsmedizin der Johannes Gutenberg-Universität Mainz. His research has been pivotal in advancing our understanding of immune responses and therapeutic strategies.
Collaborations
Tobias has collaborated with notable colleagues such as Christian Becker and Franz-Josef Schneider. Their joint efforts have contributed to the development of innovative solutions in the field of immunology.
Conclusion
Tobias Bopp's work exemplifies the impact of innovative research on medical science. His patents and collaborations highlight his commitment to advancing healthcare through scientific discovery.